tirzepatide cardiovascular outcomes trial results august 2025 In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Semaglutide 5mg Dose:7mg Frontiers | Release of

tirzepatide cardiovascular outcomes trial results august 2025 In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Semaglutide 5mg Dose:7mg Frontiers | Release of

Frontiers | Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC- pathway and modulated by endogenous H2S

The stock is down by 49% from its peak of $72.98 last week

Semaglutide 5mg

Dose:7mg

Universal Antivenom That’s right, a universal antivenom may be just on the horizon